Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1162)
Entera Bio Ltd. (ENTX)
Ellis Sean — Director
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$64.19
Total Value
$641.90K
Shares Held After
236,958
% of Holdings
4.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
104,467
Price
$30.30
Total Value
$3.17M
Shares Held After
69,302
% of Holdings
60.1%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
38,074
Price
$15.09
Total Value
$574.54K
Shares Held After
321,967
% of Holdings
10.6%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,786
Price
$18.74
Total Value
$33.46K
Shares Held After
339,392
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$33.86
Total Value
$347.02K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
904
Price
$14.90
Total Value
$13.47K
Shares Held After
171,606
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
2,732
Price
$14.90
Total Value
$40.71K
Shares Held After
374,145
% of Holdings
0.7%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.40
Total Value
$48.80K
Shares Held After
12,397
% of Holdings
16.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$16.00
Total Value
$495.06K
Shares Held After
575,235
% of Holdings
5.1%
Showing 801–850 of 1162 transactions (page 17 of 24)